Loading clinical trials...
Loading clinical trials...
SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access
Conditions
Interventions
SAPIEN M3 valve and dock
Locations
68
United States
Heart Center Hospital
Huntsville, Alabama, United States
Banner University Medical Center
Phoenix, Arizona, United States
Saint Josephs Hospital Medical Center Dignity Health
Phoenix, Arizona, United States
TMC Healthcare
Tucson, Arizona, United States
Scripps Health
La Jolla, California, United States
Good Samaritan Hospital
Los Angeles, California, United States
Start Date
November 12, 2020
Primary Completion Date
February 28, 2027
Completion Date
February 28, 2031
Last Updated
February 25, 2026
NCT05061004
NCT07450911
NCT05927441
NCT03142152
NCT06282042
NCT06255457
Lead Sponsor
Edwards Lifesciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions